MOZI-Q

Manufacturer: Xerion Dispensary Ltd.
Effective date: 2023-12-17
Label type: OTC ANIMAL DRUG LABEL
Version: 6
Source: legacy-cache
Hydrated at: 2026-08-01 21:17:53

Label at a glance#

ProductMOZI-Q

Active ingredientLEDUM PALUSTRE TWIG, URTICA URENS, GRINDELIA HIRSUTULA FLOWERING TOP, SIMABA CEDRON SEED, DELPHINIUM STAPHISAGRIA SEED

Label structure9 sections

Indications and uses

Purpose Aids in healing insect bites Alleviates skin inflammation and itching Speeds up healing in the skin following physical irritation Relieves itch from insect stings and bites Relieves itch from insect stings and bites

Dosage and administration

Directions Pets chew 1 tablet daily, or every 2-3 hours before going outside or when bug bites are present, up to a maximum of 8 tablets daily, or as directed by a health care practitioner. For best results, take between meals.

Contacts and useful links#

PhoneLabel contact1-877-937-4661

Websitewww.mozi-q.com

www.mozi-q.com

Label contents#

Full prescribing information#

Medicinal ingredients Active Ingredients (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Drug Facts

Active Ingredient ( in each tablet)

Wild Rosemary (Ledum palustre (leafy twigs)) 3 X

Dwarf Nettle (Urtica urens (whole plant)) 6 X

Grindelia (Grindelia (aerial part)) 6 C

Cedron (Cedron (seed)) 4 C

Stavesacre (Staphysagria (seeds)) 4 X

Medicinal ingredients:

Ledum palustre 3 X, Urtica urens 6 X, Grindelia 6 C, Cedron 4 C, Staphysagria 4 X

Uses

OTC - PURPOSE SECTION

Purpose

Aids in healing insect bites

Alleviates skin inflammation and itching

Speeds up healing in the skin following physical irritation

Relieves itch from insect stings and bites

Warnings

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Warnings

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control immediately.

For Pets

INDICATIONS & USAGE SECTION

Uses

Reduces typical redness and itching from bug bites

For Pets

Homeopathic remedy used for reducing the frequency and severity of insect bites.

Warnings

WARNINGS SECTION

Warnings

Stop use and ask a doctor if symptoms persist or worsen

If pregnant or breast-feeding, ask a health professional before use

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions

Pets chew 1 tablet daily, or every 2-3 hours before going outside or when bug bites are present, up to a maximum of 8 tablets daily, or as directed by a health care practitioner. For best results, take between meals.

Non-Medicinal ingredients Inactive Ingredients

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Compressible Sugar, Dextrose NF, Sorbitol, Magnesium Stearate, Colloidal Silicon Dioxide.

Non-Medicinal ingredients:

Compressible Sugar, Dextrose NF, Sorbitol, Magnesium Stearate, Colloidal Silicon Dioxide.

Questions or Comments? Other Information

OTHER SAFETY INFORMATION

Questions or Comments?

For further information or serious adverse reporting

By Phone 1-877-XERION-1 (1-877-937-4661)

By Mail 524 Union Street #335

San Francisco, CA 94133

Learn more online at www.mozi-q.com

Other Information

Blister packs and packaging have been tampered sealed for your protection

Protect from moisture

Minimize contact with electronic devices

Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MOZI-Q

For Pets

30 Chewable Tablets

Made in Canada

Maunfactured for and distributed by

Xerion Dispensary Ltd.

150, 4625 Varsity Drive NW

Calgary, Alberta, Canada T3A 0Z9

BLISTER PACKS AND PACKAGING HAVE BEEN TAMPERED SEALED FOR YOUR PROTECTION.

Directions of Use:

Chew 1 tablet daily, or every 2-3 hours, to a maximum of 8 tablets daily, or as directed by a health care practitioner. Consult a health care practitoner before use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen.

Xerion_MOZI-Q

res

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
DELPHINIUM STAPHISAGRIA SEED	ACTIVE INGREDIENT	00543AP1JV	1
GRINDELIA HIRSUTULA FLOWERING TOP	ACTIVE INGREDIENT	IDB0NAZ6AI	1
LEDUM PALUSTRE TWIG	ACTIVE INGREDIENT	877L01IZ0P	1
SIMABA CEDRON SEED	ACTIVE INGREDIENT	KHI40967MV	1
URTICA URENS	ACTIVE INGREDIENT	IHN2NQ5OF9	1
DELPHINIUM STAPHISAGRIA SEED	ACTIVE MOIETY	00543AP1JV	1
GRINDELIA HIRSUTULA FLOWERING TOP	ACTIVE MOIETY	IDB0NAZ6AI	1
LEDUM PALUSTRE TWIG	ACTIVE MOIETY	877L01IZ0P	1
SIMABA CEDRON SEED	ACTIVE MOIETY	KHI40967MV	1
URTICA URENS	ACTIVE MOIETY	IHN2NQ5OF9	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
SORBITOL	INACTIVE INGREDIENT	506T60A25R	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

MOZI-Q
Ledum Palustre Twig, Urtica Urens, Grindelia Hirsutula Flowering Top, Simaba Cedron Seed, Delphinium Staphisagria Seed
LEDUM PALUSTRE TWIG
URTICA URENS
GRINDELIA HIRSUTULA FLOWERING TOP
SIMABA CEDRON SEED
DELPHINIUM STAPHISAGRIA SEED
SUCROSE
DEXTROSE
SORBITOL
MAGNESIUM STEARATE
SILICON DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
53590-101	53590-101-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
LEDUM PALUSTRE TWIG	877L01IZ0P	ACTIB
URTICA URENS	IHN2NQ5OF9	ACTIB
GRINDELIA HIRSUTULA FLOWERING TOP	IDB0NAZ6AI	ACTIB
SIMABA CEDRON SEED	KHI40967MV	ACTIB
DELPHINIUM STAPHISAGRIA SEED	00543AP1JV	ACTIB
SUCROSE	C151H8M554	IACT
DEXTROSE	IY9XDZ35W2	IACT
SORBITOL	506T60A25R	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 201 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET / ORAL	183.66 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL		980 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	CREAM, AUGMENTED / TOPICAL	15 %w/w		Exact identifier — unii candidate 44 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	TABLET / SUBLINGUAL	50.5 mg		Exact identifier — unii candidate 44 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SOLUTION / NASAL	25 mg/1ml		Exact identifier — unii candidate 44 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	POWDER / TOPICAL		104 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TAMPON / VAGINAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	INJECTION / INTRAMUSCULAR	5 %w/v		Exact identifier — unii candidate 21 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	RING / VAGINAL		2 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SUSPENSION / ORAL		45000 mg	Exact identifier — unii candidate 44 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, LIQUID FILLED / ORAL		106 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE PARTICLES / ORAL		170 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	PELLET / ORAL		24 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET / SUBLINGUAL	115.78 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET, CHEWABLE / ORAL		1286 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	INHALANT / ORAL	0.08 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SUSPENSION / ORAL		2553 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	SUSPENSION, EXTENDED RELEASE / ORAL		71 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	PASTE, DENTIFRICE / DENTAL	14 %w/w		Exact identifier — unii candidate 44 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / TOPICAL		6 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	SYRUP / ORAL	620 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / SUBCUTANEOUS	0.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	EMULSION / TOPICAL	7 %w/w		Exact identifier — unii candidate 44 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	SUSPENSION / RECTAL	46.18 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	INJECTION / SUBCUTANEOUS	4.7 %w/v		Exact identifier — unii candidate 44 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	PASTILLE / ORAL	826 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SYSTEM / TRANSDERMAL		35 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	GUM, CHEWING / BUCCAL		5110 mg	Exact identifier — unii candidate 44 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MOZI-Q	LEDUM PALUSTRE TWIG, URTICA URENS, SIMABA CEDRON SEED, DELPHINIUM STAPHISAGRIA SEED, GRINDELIA HIRSUTULA FLOWERING TOP	Xerion Dispensary Ltd.	63e62403-b45c-46c1-9c41-639c673d8204	2025-12-16	Warnings	Name fallback brand name: MOZI-Q
Ledum Palustre 30c	LEDUM PALUSTRE TWIG	SEVENE USA	bfb87fe2-5e88-4685-9433-34157ab90032	2025-02-10	Warnings	Name fallback generic name: LEDUM PALUSTRE TWIG
Ledum palustre	LEDUM PALUSTRE TWIG	Boiron	bfa48c40-7be8-11e6-8197-424c58303031	2023-07-20		Name fallback generic name: LEDUM PALUSTRE TWIG

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.